Recombinant Human CXCL11 Protein，His

CXCL11, also known as interferon-inducible T cell alpha chemoattractant (I-TAC), is a chemokine that plays a crucial role in the immune response by attracting T cells and natural killer (NK) cells to sites of inflammation or infection. Its importance is underscored in various pathological conditions, including viral infections, autoimmune diseases, and cancer. The recombinant protein form of CXCL11 has garnered increasing attention in research due to its potential therapeutic applications, particularly in enhancing immune response and modulating inflammatory processes. Studies have shown that CXCL11 can facilitate the migration of immune cells, which is vital for effective antitumor immunity and the coordination of immune responses. Furthermore, CXCL11's unique ability to bind to and activate its receptors, CXCR3-A and CXCR3-B, makes it a target for therapeutic interventions aimed at reprogramming the immune system. Given its dual role in both promoting and inhibiting immune responses, understanding the mechanisms of CXCL11 function and its spatial regulation in the immune landscape may provide critical insights into developing novel treatments for cancers and debilitating chronic inflammatory conditions. Consequently, investigating recombinant forms of CXCL11 could lead to advances in immunotherapy, providing new avenues for manipulating immune responses in a controlled manner.